CMG Pharmaceutical Co (XKRX:058820) 3-Year Revenue Growth Rate : 14.60% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is CMG Pharmaceutical Co 3-Year Revenue Growth Rate?

CMG Pharmaceutical Co's Revenue per Share for the three months ended in Dec. 2023 was ₩151.96.

During the past 12 months, CMG Pharmaceutical Co's average Revenue per Share Growth Rate was 9.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of CMG Pharmaceutical Co was 48.70% per year. The lowest was -23.10% per year. And the median was 9.50% per year.

Competitive Comparison of CMG Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, CMG Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CMG Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CMG Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where CMG Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.

CMG Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

CMG Pharmaceutical Co (XKRX:058820) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

CMG Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of CMG Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CMG Pharmaceutical Co (XKRX:058820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

Cheongdam-dong 18-20, No. B01, Gangnam-gu, Seoul, KOR, 135-949

Website

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co Ltd is the sole pharmaceutical company and an affiliate company of CHA Health Systems. CHA Health Systems are integrated systems which include medical school, pharmacy school, research institutes, general hospitals and many affiliates which are related to stem cell research, biotechnology and pharmaceutical business all over the world.

CMG Pharmaceutical Co (XKRX:058820) Headlines

No Headlines